These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16595348)

  • 1. The Addiction Severity Index at 25: origins, contributions and transitions.
    McLellan AT; Cacciola JC; Alterman AI; Rikoon SH; Carise D
    Am J Addict; 2006; 15(2):113-24. PubMed ID: 16595348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of a dually diagnosed gay male patient: a psychotherapy perspective.
    Ruiz P; Lile B; Matorin AA
    Am J Psychiatry; 2002 Feb; 159(2):209-15. PubMed ID: 11823261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Descriptive studies of the use of the Addiction Severity Index in France].
    Martin C; Grabot D; Auriacombe M; Brisseau S; Daulouède JP; Tignol J
    Encephale; 1996; 22(5):359-63. PubMed ID: 9035992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent validity of the addiction severity index.
    Kosten TR; Rounsaville BJ; Kleber HD
    J Nerv Ment Dis; 1983 Oct; 171(10):606-10. PubMed ID: 6619823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline personality and substance use in women.
    Feske U; Tarter RE; Kirisci L; Pilkonis PA
    Am J Addict; 2006; 15(2):131-7. PubMed ID: 16595350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French version of the addiction severity index (5th Edition): validity and reliability among Swiss opiate-dependent patients. French validation of the Addiction Severity Index.
    Krenz S; Dieckmann S; Favrat B; Spagnoli J; Leutwyler J; Schnyder C; Daeppen JB; Besson J
    Eur Addict Res; 2004; 10(4):173-9. PubMed ID: 15367819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment.
    Colpaert K; De Maeyer J; Broekaert E; Vanderplasschen W
    Eur Addict Res; 2013; 19(4):173-83. PubMed ID: 23257413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
    Pozzi G; Martinotti G; Reina D; Dario T; Frustaci A; Janiri L; Bria P
    Subst Use Misuse; 2008; 43(5):722-32. PubMed ID: 18393086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychosocial survey of drunken drivers within the KAPUBRA project. A new interview technique suitable for matching the right treatment with the right client].
    Andrén A; Bergman H; Laurell H; Schlyter F
    Lakartidningen; 2001 Aug; 98(32-33):3426-32. PubMed ID: 11526664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is addiction an illness--can it be treated?
    McLellan AT
    Subst Abus; 2002 Sep; 23(3 Suppl):67-94. PubMed ID: 23580988
    [No Abstract]   [Full Text] [Related]  

  • 14. Reliability and validity of the Cocaine Selective Severity Assessment.
    Kampman KM; Volpicelli JR; McGinnis DE; Alterman AI; Weinrieb RM; D'Angelo L; Epperson LE
    Addict Behav; 1998; 23(4):449-61. PubMed ID: 9698974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of family history of alcohol and drug abuse in cocaine abusers.
    Compton WM; Cottler LB; Ridenour T; Ben-Abdallah A; Spitznagel EL
    Am J Addict; 2002; 11(2):85-94. PubMed ID: 12028739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study.
    Petrakis I; Carroll K; Gordon L; Cushing G; Rounsaville B
    J Addict Dis; 1994; 13(3):25-32. PubMed ID: 7734457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crack users show high rates of antisocial personality disorder, engagement in illegal activities and other psychosocial problems.
    Paim Kessler FH; Barbosa Terra M; Faller S; Ravy Stolf A; Carolina Peuker A; Benzano D; ; Pechansky F
    Am J Addict; 2012; 21(4):370-80. PubMed ID: 22691017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual diagnosis--policy and practice in Italy.
    Carrà G; Clerici M
    Am J Addict; 2006; 15(2):125-30. PubMed ID: 16595349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity in substance abuse (opioids).
    Ahmad B; Mufti KA; Farooq S
    J Pak Med Assoc; 2001 May; 51(5):183-6. PubMed ID: 11467240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for psychopathology in the clinical practice.
    Eland-Goossensen A; van de Goor I; Garretsen H; Schudel J
    J Subst Abuse Treat; 1997; 14(6):585-91. PubMed ID: 9437632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.